Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse model.
about
Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control StudiesThe application of hyaluronic acid-derivatized carbon nanotubes in hematoporphyrin monomethyl ether-based photodynamic therapy for in vivo and in vitro cancer treatment.In vitro assessment of choline dihydrogen phosphate (CDHP) as a vehicle for recombinant human interleukin-2 (rhIL-2).In vivo animal models for studying brain metastasis: value and limitations.IL-2 immunotherapy in chronically SIV-infected Rhesus macaques.
P2860
Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse model.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Skin tumor responsiveness to i ...... n immunocompetent mouse model.
@en
Skin tumor responsiveness to i ...... n immunocompetent mouse model.
@nl
type
label
Skin tumor responsiveness to i ...... n immunocompetent mouse model.
@en
Skin tumor responsiveness to i ...... n immunocompetent mouse model.
@nl
prefLabel
Skin tumor responsiveness to i ...... n immunocompetent mouse model.
@en
Skin tumor responsiveness to i ...... n immunocompetent mouse model.
@nl
P2093
P2860
P1476
Skin tumor responsiveness to i ...... an immunocompetent mouse model
@en
P2093
David M Foureau
Iain H McKillop
Jonathan C Salo
Richard L White
P2860
P2888
P304
P356
10.1007/S00262-011-1035-1
P577
2011-06-03T00:00:00Z